Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2005 | 06-2005 | 03-2005 | 12-2004 | 09-2004 | |
| Operating Expenses | 3,760 | 3,360 | 2,200 | 2,320 | 3,030 |
| Operating Income | -3,760 | -3,360 | -2,200 | -2,320 | -3,030 |
| Other Income | 320 | 310 | 180 | 70 | 120 |
| Pre-tax Income | -3,440 | -3,050 | -2,020 | -2,250 | -2,910 |
| Net Income Continuous | -3,445 | -3,058 | -2,028 | -2,249 | -2,910 |
| Net Income | $-3,445 | $-3,058 | $-2,028 | $-2,249 | $-2,910 |
| EPS Basic Total Ops | -40.82 | -36.01 | -28.81 | -31.21 | -40.82 |
| EPS Basic Continuous Ops | -41.26 | -36.62 | -27.67 | -32.41 | -41.93 |
| EPS Diluted Total Ops | -40.82 | -36.01 | -28.81 | -31.21 | -40.82 |
| EPS Diluted Continuous Ops | -41.26 | -36.62 | -27.67 | -32.41 | -41.93 |
| EBITDA(a) | $-3,730 | $-3,330 | $-2,170 | $-2,290 | $-3,000 |